PTGS2 and neoplasm: Both in vitro and in vivo studies have clearly shown that the nuclear receptor PPARβ/δ plays an important role in the progression of inflammatory diseases, and the activation of PPARβ/δ can upregulate the expression of COX-2 in tumor cells [35,36].